Cutaneous adverse effects of COVID- 19 vaccines: A cross-sectional study among AstraZeneca and Sinovac vaccine recipients at UERMMMCI

Jose Alberto  M. Lim,; Lian  C. Jamisola,; Carmela Franchesca  L. Miranda,; Cathrine Ilene  B. Ang,; Juanita Carmela  Co-Buenviaje,; Camille  B. Angeles,

Cutaneous adverse effects of COVID- 19 vaccines: A cross-sectional study among AstraZeneca and Sinovac vaccine recipients at UERMMMCI

Discipline: Medicine

Abstract:

Introduction COVID-19 has emerged as a global problem with vaccines being established as one of the best tools in its control. Of particular interest in dermatology are risks and manifestations of cutaneous reactions from such countermeasures, with strides made in documenting and associating skin reactions with vaccines against COVID-19. This study aimed to determine the incidence of cutaneous adverse reactions in recipients of recombinant ChAdOx1-S and inactivated SARS-COV-2 vaccines among healthcare personnel and employees of UERMMMCI. Methods A cross-sectional study was done were respondents, chosen through randomized stratified cluster sampling, were given a questionnaire to elicit cutaneous adverse effects associated with COVID-19 vaccines. Results There were198 respondents, of which 29.3% were male and 70.7% were female, with a mean age of 26.07 years. Of these respondents, 72 (36.36%) received recombinant ChAdOx1-S and 126 (63.64%) received inactivated SARS-COV-2 vaccine. For the first dose, cutaneous reactions developed in 6 (8.33%) recipients of recombinant ChAdOx1-S, and 2 (1.59%) recipients of inactivated SARS-COV-2. For the second dose, no reactions followed vaccination with recombinant ChAdOx1-S while 4 (3.17%) reactions developed after inactivated SARS-COV-2 vaccination. Lesions were mostly confined to the injection site presenting with erythema for both vaccine types. One urticarial, widespread reaction was associated with a second dose of inactivated SARS-COV-2 vaccine. Conclusions Adverse reactions to COVID-19 vaccinations have been documented which may be attributed to respective excipients rather than vaccine antigens. Due to the rare occurrence of severe anaphylactic reactions, vaccine use is recommended as they confer protection even to those with prior infections. Documented reactions in this study were observed to be mild and self- limiting similar to larger studies.

References:

Yuan P, Ai P, Liu Y, Ai Z, Wang Y, Cao W, Xia X & Zheng JC. Safety, Tolerability, and immunogenicity of COVID-19 vaccines: A systematic review and meta-analysis 2020. medRxiv : the preprint server for health sciences 2020.11.03.20224998. https://doi.org/10.1101/2020.11.03.20224998
Reiter PL, Pennell ML & Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine 2020. doi:10.1016/j.vaccine.2020.08.043
Blumenthal KG, Freeman EE, Saff RR, et al. Delayed large local reactions to mRNA-1273 vaccine against SARSCoV-2. N Engl J Med 2021 Apr 1;384(13):1273- 7. doi: 10.1056/NEJMc2102131. Epub 2021 Mar 3.
Wei N, Fishman M, Wattenberg D, Gordon M & Lebwohl M. COVID arm: A reaction to the Moderna vaccine. JAAD case reports 2021; 10: 92–5. https://doi.org/10.1016/j. jdcr.2021.02.014
McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol 2021;85(1):46-55. oi: 10.1016/j. jaad.2021.03.092
Gambichler T, Boms S, Susok L, et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol 2022;36(2):172-80. doi:10.1111/jdv.17744
Wong N, Cascardo CA, Mansour, M, Qian V & Potts GA. A review of pityriasis rosea in relation to SARS-CoV-2/ COVID-19 Infection and Vaccination. Cureus 2023; 15(5): e38772. https://doi.org/10.7759/cureus.38772
van Dam CS, Lede I, Schaar J, Al-Dulaimy M, Rösken R & Smits M. Herpes zoster after COVID vaccination. International journal of infectious diseases : IJID 2021; 111: 169–71. https://doi.org/10.1016/j.ijid.2021.08.048
Dash S, Sirka CS, Mishra S & Viswan P. COVID-19 vaccine-induced Stevens-Johnson syndrome. Clinical and experimental dermatology 2021; 46(8): 1615–7. https://doi.org/10.1111/ced.14784
Kounis NG, Koniari I, de Gregorio C, et al. Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations. Vaccines 2021; 9(3): 221. https://doi.org/10.3390/vaccines9030221.
Bellinato F, Fratton Z, Girolomoni G & Gisondi P. Cutaneous adverse reactions to SARS-CoV-2 vaccines: A systematic review and meta-analysis. Vaccines 2022; 10(9): 1475. https://doi.org/10.3390/vaccines10091475